» Articles » PMID: 22645320

Integrative Analysis of Gene and MiRNA Expression Profiles with Transcription Factor-miRNA Feed-forward Loops Identifies Regulators in Human Cancers

Overview
Specialty Biochemistry
Date 2012 May 31
PMID 22645320
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

We describe here a novel method for integrating gene and miRNA expression profiles in cancer using feed-forward loops (FFLs) consisting of transcription factors (TFs), miRNAs and their common target genes. The dChip-GemiNI (Gene and miRNA Network-based Integration) method statistically ranks computationally predicted FFLs by their explanatory power to account for differential gene and miRNA expression between two biological conditions such as normal and cancer. GemiNI integrates not only gene and miRNA expression data but also computationally derived information about TF-target gene and miRNA-mRNA interactions. Literature validation shows that the integrated modeling of expression data and FFLs better identifies cancer-related TFs and miRNAs compared to existing approaches. We have utilized GemiNI for analyzing six data sets of solid cancers (liver, kidney, prostate, lung and germ cell) and found that top-ranked FFLs account for ∼20% of transcriptome changes between normal and cancer. We have identified common FFL regulators across multiple cancer types, such as known FFLs consisting of MYC and miR-15/miR-17 families, and novel FFLs consisting of ARNT, CREB1 and their miRNA partners. The results and analysis web server are available at http://www.canevolve.org/dChip-GemiNi.

Citing Articles

Identification and validation of palmitoylation-related biomarkers in gestational diabetes mellitus.

Zhang K, Shi X, Bian R, Shi W, Yang L, Ren C Sci Rep. 2025; 15(1):8019.

PMID: 40055514 PMC: 11889268. DOI: 10.1038/s41598-025-93046-w.


Predicting the Effect of miRNA on Gene Regulation to Foster Translational Multi-Omics Research-A Review on the Role of Super-Enhancers.

Das S, Rai S Noncoding RNA. 2024; 10(4).

PMID: 39195574 PMC: 11357235. DOI: 10.3390/ncrna10040045.


Metabolic reprogramming by miRNAs in the tumor microenvironment: Focused on immunometabolism.

Alshahrani S, Ibrahim Y, Turki Jalil A, Altoum A, Achmad H, Zabibah R Front Oncol. 2022; 12:1042196.

PMID: 36483029 PMC: 9723351. DOI: 10.3389/fonc.2022.1042196.


Emerging Role of CREB in Epithelial to Mesenchymal Plasticity of Pancreatic Cancer.

Mehra S, Singh S, Nagathihalli N Front Oncol. 2022; 12:925687.

PMID: 35800049 PMC: 9253527. DOI: 10.3389/fonc.2022.925687.


Multiomics Analysis Identifies SOCS1 as Restraining T Cell Activation and Preventing Graft-Versus-Host Disease.

Guo H, Li R, Wang M, Hou Y, Liu S, Peng T Adv Sci (Weinh). 2022; 9(21):e2200978.

PMID: 35585676 PMC: 9313503. DOI: 10.1002/advs.202200978.


References
1.
Garzon R, Marcucci G, Croce C . Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov. 2010; 9(10):775-89. PMC: 3904431. DOI: 10.1038/nrd3179. View

2.
Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

3.
Fujiwara T, Hiramatsu M, Isagawa T, Ninomiya H, Inamura K, Ishikawa S . ASCL1-coexpression profiling but not single gene expression profiling defines lung adenocarcinomas of neuroendocrine nature with poor prognosis. Lung Cancer. 2011; 75(1):119-25. DOI: 10.1016/j.lungcan.2011.05.028. View

4.
Guo H, Ingolia N, Weissman J, Bartel D . Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature. 2010; 466(7308):835-40. PMC: 2990499. DOI: 10.1038/nature09267. View

5.
El Baroudi M, Cora D, Bosia C, Osella M, Caselle M . A curated database of miRNA mediated feed-forward loops involving MYC as master regulator. PLoS One. 2011; 6(3):e14742. PMC: 3048388. DOI: 10.1371/journal.pone.0014742. View